冠状动脉内注射腺苷与维拉帕米治疗急性冠状动脉综合征介入术中缓.PDFVIP

中国介入影像与治疗学 2005 年第 2 卷第 6 期 　Chin J Int erv Imaging Ther ,2005 ,Vol 2 ,No 6 4·37 · Effect and safety of intracoronary adenosine and verapamil on slowreflow phenomenon f ollowing PCI in patients with acute coronary syndrome GA N L ij un , D I N G N aix i , Z HA N G Chunh ui , L I Qi ngx i an , W EI Guanghe , Z H A N G H uil i ng , WA N G Yueqi ang ( ) D ep a rtment of Ca r d iology , t he af f i l i ate d hosp i t al of J i ni ng M e d ical Col leg e , J i ni ng 272 129 , Chi na ABSTRACT 　Objective 　To cont rast t he effect and safet y of int racoronary adeno sine wit h verap amil on slowreflow p he nomenon following p ercut aneou s coronary int ervention ( PCI) in p atient s wit h acut e coronary syndrome (A CS) . Methods 　 33 p atient s wit h A CS who develop ed slowreflow p henomenon during PCI were divided into adeno sine group ( 17 cases) and verap amil group ( 16 cases) . Patient s in adeno sine group were given 3 mg adeno sine int racoronary t hrough guiding cat het er and p atient s in verap amil group were given 2 . 5 mg verap amil . 1 min , 5 min and 10 min lat er coronary flow wa s a ssessed by t he TIM I f rame count met ho d ( TFC) . And t he changes of elect rocar diogram and blood p ressure were writt en down . Re sults 　Before t he admini st ration of int racoronary drugs , t he TFC in adeno sine group and verap amil group was 87 . 9 ±15 . 3 and 89 . 5 ±17 . 4 . Aft er t he drugs were given , t he TFC in adeno sine group decrea s